BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 25041074)

  • 1. Primary sclerosing cholangitis increases the risk for pancreatitis after endoscopic retrograde cholangiopancreatography.
    von Seth E; Arnelo U; Enochsson L; Bergquist A
    Liver Int; 2015 Jan; 35(1):254-62. PubMed ID: 25041074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of risk factors associated with endoscopic retrograde cholangiopancreatography for patients with liver cirrhosis: a multicenter, retrospective, clinical study.
    Li J; Hu J; Li P; Wu Y; Wang Y; Ji M; Hua H; Ran W; Pan Y; Zhang S
    Chin Med J (Engl); 2022 Oct; 135(19):2319-2325. PubMed ID: 36103988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Risks of Post-ERCP Adverse Events in Patients with Asymptomatic and Symptomatic Choledocholithiasis: A Systematic Review and Meta-Analysis.
    Obaitan I; Mohamed MFH; Beran A; Rosenheck M; Obomanu ET; Berzin TM; Ramai D; Wehbe H; Aziz M; Mahendraker N; Al-Haddad M; Easler JJ; Fogel EL
    Dig Dis Sci; 2024 May; 69(5):1880-1888. PubMed ID: 38555329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of COVID-19 on hospitalizations that underwent endoscopic retrograde cholangiopancreatography in the United States.
    Dahiya DS; Pinnam BSM; Chandan S; Gangwani MK; Ali H; Deliwala S; Bapaye J; Aziz M; Merza N; Inamdar S; Al-Haddad M; Sharma N
    Surg Endosc; 2024 Jan; 38(1):202-211. PubMed ID: 37957298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased ERCP-related adverse event from premature urgent ERCP following symptom onset in acute biliary pancreatitis with cholangitis.
    Lee SY; Park SH; Do MY; Lee DK; Jang SI; Cho JH
    Sci Rep; 2024 Jun; 14(1):13663. PubMed ID: 38871990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic retrograde cholangiopancreatography in cirrhosis - a systematic review and meta-analysis focused on adverse events.
    Mashiana HS; Dhaliwal AS; Sayles H; Dhindsa B; Yoo JW; Wu Q; Singh S; Siddiqui AA; Ohning G; Girotra M; Adler DG
    World J Gastrointest Endosc; 2018 Nov; 10(11):354-366. PubMed ID: 30487946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERCP-related adverse events: incidence, mechanisms, risk factors, prevention, and management.
    Rivas A; Pherwani S; Mohamed R; Smith ZL; Elmunzer BJ; Forbes N
    Expert Rev Gastroenterol Hepatol; 2023; 17(11):1101-1116. PubMed ID: 37899490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events associated with endoscopic retrograde cholangiopancreatography: protocol for a systematic review and meta-analysis.
    Forbes N; Leontiadis GI; Vaska M; Elmunzer BJ; Yuan Y; Bishay K; Meng ZW; Iannuzzi J; O'Sullivan DE; Mah B; Partridge ACR; Henderson AM; Qureshi A; Keswani RN; Wani S; Bridges RJ; Heitman SJ; Hilsden RJ; Ruan Y; Brenner DR
    BMJ Open; 2021 Aug; 11(8):e053302. PubMed ID: 34404717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of endoscopic retrograde cholangiopancreatography (ERCP) in cirrhosis compared to non-cirrhosis and effect of Child-Pugh score on post-ERCP complications: a systematic review and meta-analysis.
    Tarar ZI; Farooq U; Gandhi M; Saleem S; Daglilar E
    Clin Endosc; 2023 Sep; 56(5):578-589. PubMed ID: 37157959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Immunoglobulin G4 in Outcomes of Primary Sclerosing Cholangitis.
    Vujasinovic M; Said K; Villard C; Carlsson J; Poli C; Maisonneuve P; Löhr JM
    J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of acute pancreatitis in patients with post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis: findings from a National Cohort.
    Farooq U; Tarar ZI; Kamal F; Schlachterman A; Kumar A; Loren DE; Kowalski TE
    HPB (Oxford); 2024 Feb; 26(2):313-315. PubMed ID: 37880009
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of Trainee Involvement on Pediatric ERCP Procedures: Results From the Pediatric ERCP Initiative.
    Gupta R; Khalaf RT; Morrison J; Amankwah E; Ruan W; Fishman DS; Barth BA; Liu QY; Giefer M; Kim KM; Martinez M; Dall'oglio L; Torroni F; De Angelis P; Faraci S; Bitton S; Dua K; Werlin S; Gugig R; Huang C; Mamula P; Quiros JA; Zheng Y; Piester T; Grover A; Fox VL; Wilsey M; Troendle DM
    J Pediatr Gastroenterol Nutr; 2023 Jul; 77(1):126-130. PubMed ID: 36976177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary sclerosing cholangitis hospitalizations in the United States: characteristics and predictors of clinical outcomes.
    Elfert K; Abosheaishaa H; Aboursheid T; Beran A; Ahmed M; Musallam R; Al-Taee A
    Proc (Bayl Univ Med Cent); 2023; 36(6):700-704. PubMed ID: 37829220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of center and endoscopist ERCP volume on ERCP outcomes: a systematic review and meta-analysis.
    Teles de Campos S; Papaefthymiou A; Florou T; Facciorusso A; Arvanitakis M; Devière J; Gkolfakis P
    Gastrointest Endosc; 2023 Sep; 98(3):306-315.e14. PubMed ID: 37201726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the current role of endoscopy in primary sclerosing cholangitis?
    Tharian B; George NE; Tham TC
    World J Gastrointest Endosc; 2015 Aug; 7(10):920-7. PubMed ID: 26265986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SASE, Success and Adverse event Score in Endoscopic Retrograde Cholangiopancreatography: a Novel Grading System.
    Maieron A; Duller C; Püspök A; Steiner E; Kapral C
    BMC Gastroenterol; 2023 Sep; 23(1):314. PubMed ID: 37715151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic steatosis: Identification of yet another "new" modifiable high-risk factor for post-ERCP pancreatitis?
    Weston BR
    Gastrointest Endosc; 2024 Feb; 99(2):224-226. PubMed ID: 38237965
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse events in older patients undergoing ERCP: a systematic review and meta-analysis.
    Day LW; Lin L; Somsouk M
    Endosc Int Open; 2014 Mar; 2(1):E28-36. PubMed ID: 26134610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cohort profile: the Swedish Pancreatitis Cohort (SwePan).
    Selin D; Yang B; Lindblad M; Arnelo U; Nilsson M; Sadr-Azodi O; Maret-Ouda J
    BMJ Open; 2022 May; 12(5):e059877. PubMed ID: 35623760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for post‑retrograde cholangiopancreatography pancreatitis in patients with common bile duct stones: A meta‑analysis.
    Zhou B; Zhao L; Xing X; Wang H; Kuwantai A; Chen K
    Exp Ther Med; 2024 Jan; 27(1):32. PubMed ID: 38125338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.